The hidden evolution inside your immune system — and what it means for vaccines
Every time you fight an infection or respond to a vaccine, your immune system runs a miniature evolutionary competition. The cells that produce better antibodies win and multiply.
When the body encounters a pathogen, B cells — a type of white blood cell — do more than simply produce antibodies. Inside structures called germinal centres, tiny oval nodes found in lymph nodes and the spleen, B cells undergo an accelerated evolutionary process. They mutate rapidly, and the variants that bind more tightly to the invading pathogen — or to a vaccine protein — are selectively amplified. The result is a progressive refinement of antibody quality, tuned precisely to the current threat.
This process, known as affinity maturation, is fundamental to a strong and lasting immune response. It is also why vaccines typically require multiple doses: each repeated exposure drives another round of selection and improvement. But the precise mathematics underlying this process — how much does stronger binding actually increase a B cell’s chances of producing more offspring? — remained unknown. Researchers refer to this relationship as the ‘affinity–fitness response function’, and until now, no one had been able to determine its shape.
Using simulation as a microscope
The research team developed an approach they call simulation-based deep learning. They built detailed computer models of germinal centres, ran those simulations under varying assumptions about the affinity–fitness relationship, and then trained a neural network to identify which simulated scenarios best matched real biological data from actual B cells. This allowed them to infer the unknown response function without having to measure it directly — a significant technical achievement.
The implications for vaccine design are direct. Knowing how strongly affinity-based selection operates inside germinal centres makes it possible to engineer vaccine antigens that drive this selection more efficiently, producing high-quality, long-lived antibody responses more reliably. This is particularly relevant for vaccines against rapidly mutating viruses like influenza or future SARS variants, where the demands on antibody quality are exceptionally high.
A method with reach beyond this finding
The methodological contribution may be as significant as the specific result. Simulation-based inference — using computational models to estimate biological parameters that cannot be measured directly — is an emerging technique with applications across multiple areas of biology. Combined with deep learning, it becomes capable of mapping complex, non-linear processes that traditional mathematical approaches struggle to capture.
Germinal centres are also implicated in autoimmune disease: when the selection process goes wrong, B cells can produce antibodies that attack the body’s own tissues. A deeper understanding of the evolutionary dynamics in these structures could therefore yield insights relevant to conditions like lupus or rheumatoid arthritis — though translating that understanding into clinical applications remains a long-term prospect.